<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03472261</url>
  </required_header>
  <id_info>
    <org_study_id>KU GOKAEK 2018/8</org_study_id>
    <nct_id>NCT03472261</nct_id>
  </id_info>
  <brief_title>Integrated Management of Pronation Deformity in Cerebral Palsy</brief_title>
  <official_title>A Randomized Controlled Trial on Integrated Management of Pronation Deformity of Children With Cerebral Palsy Treated by Botulinum Toxin-A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pronation deformity is a very common problem in children with cerebral palsy. This deformity
      is usually has neural and non-neural aspects. In this clinical trial the aim is to show the
      importance of combine treatment approach with pharmacological and non-pharmacological
      modalities. .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spasticity is not only the most common motor disorder but also the main cause of slowly
      developing contractures in children with cerebral palsy. Pronation deformity which is a very
      common problem in children with cerebral palsy is primarily due to spasticity of the pronator
      muscles. Reduced strength and loss of control of the supinator muscles and soft tissue and
      joint contractures usually coexist with spasticity of pronator muscles. There is very limited
      information about how to treat this deformity in the current literature.

      In this prospective, randomized, controlled clinical trial the aim is to show the
      effectiveness of twister, and home exercise program in an integrated approach with BoNT-A
      injections on spasticity, and passive range of motion (pROM) of children with CP having
      pronation deformity.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change from baseline Modified Ashworth Scale (MAS)</measure>
    <time_frame>Week 12</time_frame>
    <description>Tone measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean change from baseline passive range of supination</measure>
    <time_frame>Week 12</time_frame>
    <description>Range of motion measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change from baseline angle of catch (XV3) Tardieu scale</measure>
    <time_frame>Week 12</time_frame>
    <description>Spasticity measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change from baseline active range of supination</measure>
    <time_frame>Week 12</time_frame>
    <description>Active range of motion</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Assisting Hand Assessment (AHA)</measure>
    <time_frame>Week 12</time_frame>
    <description>Bilateral hand use</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated by Botulinum toxin A and twister and specific home exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Therapy Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated by Botulinum toxin A and specific home exercise program</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <description>Dysport</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_label>Conventional Therapy Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Upper extremity orthoses</intervention_name>
    <description>Twister</description>
    <arm_group_label>Experimental Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home exercise program</intervention_name>
    <description>Specific exercises for pronation deformity</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_label>Conventional Therapy Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of cerebral palsy

          -  MAS score of pronator muscles at least 2

          -  Gross Motor Functional Classification Scale level of I-IV

          -  Scheduled to receive botulinum toxin injections to pronator teres and/or -pronator
             quadratus muscles besides other spastic upper extremity muscles

        Exclusion Criteria:

          -  Severe cognitive or behavioural problems

          -  Less than 40 degrees of available passive range of motion in pronation

          -  Severe dystonia in the affected upper limb

          -  Received orthopedic surgery to affected upper limb
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melike Akarsu, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kocaeli University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melike Akarsu, MSc</last_name>
    <phone>5326624633</phone>
    <email>sirinmelik@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nigar Dursun, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kocaeli University</name>
      <address>
        <city>Kocaeli</city>
        <zip>41050</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nigar Dursun, MD</last_name>
      <phone>905334322568</phone>
      <email>nigard@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Melike Akarsu, BA</last_name>
      <phone>905326624633</phone>
      <email>sirinmelik@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Nigar Dursun</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>cerebral palsy</keyword>
  <keyword>botulinum toxin-A</keyword>
  <keyword>pronator deformity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

